Axel Hauschild - Researcher Profile | RDL Research Database

Publications

2 shown

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman , Axel Hauschild , Caroline Robert +25 more

Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation. (Funded by Hoffmann-La ...

2011 New England Journal of Medicine 7590 citations

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert , L. Thomas , Igor Bondarenko +21 more

Ipilimumab (at a dose of 10 mg per kilogram) in combination with dacarbazine, as compared with dacarbazine plus placebo, improved overall survival in patients with previously un...

2011 New England Journal of Medicine 4405 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 11,995
Institution: Christian-Albrechts-Universität zu Kiel

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1212-9587

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.